Biomarkers and Drug Targets
Bioneer offers a range of services related to the identification, validation and documentation of disease relevant biomarkers and drug targets. These services comprise a toolbox of molecular methods that will facilitate the pre-clinical development of both biomarkers, drug-targets and active compounds, which will be useful in diagnostic, prognostic, and therapeutic contexts, and, furthermore, serve as effective means to optimize clinical trial designs.
Bioneer offers solutions for monitoring bio-molecules including nucleic acid and proteins in biological specimens, i.e. biopsies, tissues, blood, cells, bacteria and viruses.
Consultancy assistance covers all aspects of the pre-clinical biomarker and drug target development process.